Vor Biopharma, Inc. (VOR)

NASDAQ: VOR · IEX Real-Time Price · USD
-0.22 (-2.78%)
Jan 27, 2022 2:56 PM EST - Market open

Total Valuation

Vor Biopharma has a market cap or net worth of $286.38 million. The enterprise value is $75.61 million.

Market Cap286.38M
Enterprise Value75.61M

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Vor Biopharma has 37.29 million shares outstanding. The number of shares has increased by 16,089.03% in one year.

Shares Outstanding37.29M
Shares Change (YoY)+16,089.03%
Shares Change (QoQ)+0.25%
Owned by Insiders (%)10.79%
Owned by Institutions (%)81.67%

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
PB Ratio1.23
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

EV / Earningsn/a
EV / Salesn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 25.20, with a Debt / Equity ratio of 0.08.

Current Ratio25.20
Quick Ratio24.80
Debt / Equity0.08
Debt / EBITDAn/a
Debt / FCFn/a

Financial Efficiency

Return on equity (ROE) is -40.30%, which is considered low. The company has a ROIC of -86.20%.

Return on Equity (ROE)-40.30%
Return on Assets (ROA)-30.90%
Return on Capital (ROIC)-86.20%
Revenue Per Employeen/a
Profits Per Employee-$571,377
Employee Count122
Asset Turnovern/a
Inventory Turnovern/a


Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (1Y)n/a
Total Price Change-57.33%
50-Day Moving Average11.23
200-Day Moving Average13.87
Average Volume (30 Days)95,827

Short Selling Information

Short Interest1.79M
Short % of Shares Out4.81%
Short % of Float11.16%
Short Ratio (days to cover)13.57

Income Statement

Gross Profitn/a
Operating Income-66.38M
Net Income-66.31M
Net Income Common-69.71M
Earnings Per Share (EPS)-$2.89
Full Income Statement

Balance Sheet

The company has $228.38 million in cash and $17.61 million in debt, giving a net cash position of $210.77 million or $5.65 per share.

Cash & Cash Equivalents228.38M
Total Debt17.61M
Net Cash210.77M
Net Cash Per Share$5.65
Book Value232.96M
Book Value Per Share6.25
Working Capital222.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$65.19 million and capital expenditures -$4.20 million, giving a free cash flow of -$69.39 million.

Operating Cash Flow-65.19M
Capital Expenditures-4.20M
Free Cash Flow-69.39M
FCF Per Sharen/a
Full Cash Flow Statement


Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-24.34%
FCF Yield-24.23%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Daten/a
Split Typen/a
Split Ration/a